Letter to the editor on "HTD1801 demonstrates promising potential for histologic improvements in metabolic dysfunction-associated steatohepatitis in both a preclinical and phase 2 study"

致编辑的信，主题为“HTD1801在临床前研究和2期研究中均显示出改善代谢功能障碍相关脂肪性肝炎组织学的良好潜力”。